Effects of KDT501 on metabolic parameters in insulin-resistant prediabetic humans

Journal of the Endocrine Society

Volumn 1, Issue 6, 2017, Pages 650-659

  Kern, Philip A ^a   Finlin, Brian S ^a   Ross, Dorothy ^b   Boyechko, Tania ^b   Zhu, Beibei ^a   Grayson, Neile ^c   Sims, Robert ^c   Bland, Jeffrey S ^c  

^a Barnstable Brown Diabetes and Obesity Center   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Kindex Pharmaceuticals   (United States)

Author keywords

Adiponectin; Insulin resistance; KDT501; Obesity

Indexed keywords

ADIPONECTIN; ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; KDT 501; LIPID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ADULT; AGED; ARTICLE; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; CLINICAL RESEARCH; COHORT ANALYSIS; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG STRUCTURE; FAT TOLERANCE TEST; FEMALE; GASTROESOPHAGEAL REFLUX; HEADACHE; HEMORRHOID; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NAUSEA; ORAL GLUCOSE TOLERANCE TEST; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RASH; SAMPLE SIZE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VOMITING;

EID: 85030184112     PISSN: None     EISSN: 24721972     Source Type: Journal    
DOI: 10.1210/js.2017-00202     Document Type: Article

References (26)

1. de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett. 2008;582(1):97-105
2. Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab. 2008;93(11, Suppl 1)S64-S73
3. Varma V, Yao-Borengasser A, Bodles AM, Rasouli N, Phanavanh B, Nolen GT, Kern EM, Nagarajan R, Spencer HJ III, Lee MJ, Fried SK, McGehee RE, Jr, Peterson CA, Kern PA. Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance. Diabetes. 2008;57(2): 432-439
4. Spencer M, Yao-Borengasser A, Unal R, Rasouli N, Gurley CM, Zhu B, Peterson CA, Kern PA. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am J Physiol Endocrinol Metab. 2010;299(6):E1016-E1027
5. Pasarica M, Gowronska-Kozak B, Burk D, Remedios I, Hymel D, Gimble J, Ravussin E, Bray GA, Smith SR. Adipose tissue collagen VI in obesity. J Clin Endocrinol Metab. 2009;94(12):5155-5162
6. Divoux A, Tordjman J, Lacasa D, Veyrie N, Hugol D, Aissat A, Basdevant A, Guerre-Millo M, Poitou C, Zucker JD, Bedossa P, Clément K. Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes. 2010;59(11):2817-2825
7. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;92(3):347-355
8. Pasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE, Rood JC, Burk DH, Smith SR. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes. 2009;58(3):718-725
9. Rutkowski JM, Davis KE, Scherer PE. Mechanisms of obesity and related pathologies: the macro-and microcirculation of adipose tissue. FEBS J. 2009;276(20):5738-5746
10. Desai A, Darland G, Bland JS, Tripp ML, Konda VR. META060 attenuates TNF-a-activated inflammation, endothelial-monocyte interactions, and matrix metalloproteinase-9 expression, and inhibits NF-kB and AP-1 in THP-1 monocytes. Atherosclerosis. 2012;223(1):130-136
11. Desai A, Konda VR, Darland G, Austin M, Prabhu KS, Bland JS, Carroll BJ, Tripp ML. META060 inhibits multiple kinases in the NF-kappaB pathway and suppresses LPS-mediated inflammation in vitro and ex vivo. Inflamm Res. 2009;58(5):229-234
12. Everard A, Geurts L, Van Roye M, Delzenne NM, Cani PD. Tetrahydro iso-alpha acids from hops improve glucose homeostasis and reduce body weight gain and metabolic endotoxemia in high-fat dietfed mice. PLoS One. 2012;7(3):e33858
13. Vroegrijk IO, van Diepen JA, van den Berg SA, Romijn JA, Havekes LM, van Dijk KW, Darland G, Konda V, Tripp ML, Bland JS, Voshol PJ. META060 protects against diet-induced obesity and insulin resistance in a high-fat-diet fed mouse. Nutrition. 2013;29(1):276-283
14. Konda VR, Desai A, Darland G, Grayson N, Bland JS. KDT501, a derivative from hops, normalizes glucose metabolism and body weight in rodent models of diabetes. PLoS One. 2014;9(1):e87848
15. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17): 2735-2752
16. Barrows BR, Timlin MT, Parks EJ. Spillover of dietary fatty acids and use of serum nonesterified fatty acids for the synthesis of VLDL-triacylglycerol under two different feeding regimens. Diabetes. 2005; 54(9):2668-2673
17. Rood J, Smith SR. Triglyceride concentrations and endotoxemia. Am J Clin Nutr. 2008;88(1):248-249, author reply 249-250
18. Cersosimo E, Solis-Herrera C, Trautmann ME, Malloy J, Triplitt CL. Assessment of pancreatic b-cell function: review of methods and clinical applications. Curr Diabetes Rev. 2014;10(1):2-42
19. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96(9): 939-949
20. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem. 2004;279(13):12152-12162
21. Simpson F, Whitehead JP. Adiponectin-it's all about the modifications. Int J Biochem Cell Biol. 2010; 42(6):785-788
22. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-a: direct role in obesity-linked insulin resistance. Science. 1993;259(5091):87-91
23. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest. 1995;95(5):2111-2119
24. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796-1808
25. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112(12):1821-1830
26. Di Gregorio GB, Yao-Borengasser A, Rasouli N, Varma V, Lu T, Miles LM, Ranganathan G, Peterson CA, McGehee RE, Kern PA. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes. 2005;54(8):2305-2313